These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 36721313)
1. Deep learning-based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia. Zhang X; Gleber-Netto FO; Wang S; Martins-Chaves RR; Gomez RS; Vigneswaran N; Sarkar A; William WN; Papadimitrakopoulou V; Williams M; Bell D; Palsgrove D; Bishop J; Heymach JV; Gillenwater AM; Myers JN; Ferrarotto R; Lippman SM; Pickering CR; Xiao G Cancer Med; 2023 Mar; 12(6):7508-7518. PubMed ID: 36721313 [TBL] [Abstract][Full Text] [Related]
2. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. Saintigny P; William WN; Foy JP; Papadimitrakopoulou V; Lang W; Zhang L; Fan YH; Feng L; Kim ES; El-Naggar AK; Lee JJ; Mao L; Hong WK; Lingen MW; Lippman SM J Natl Cancer Inst; 2018 Mar; 110(3):250-7. PubMed ID: 29617836 [TBL] [Abstract][Full Text] [Related]
3. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway. Liu W; Yao Y; Shi L; Tang G; Wu L J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929 [TBL] [Abstract][Full Text] [Related]
4. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209 [TBL] [Abstract][Full Text] [Related]
5. Epithelial and fibroblast SPARC expression patterns in oral leukoplakia and oral squamous cell carcinoma. Poomsawat S; Kosanwat T; Meesakul O; Sanguansin S Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):e44-e50. PubMed ID: 35165061 [TBL] [Abstract][Full Text] [Related]
6. Environmental heavy metal as a potential risk factor for the progression of oral potentially malignant disorders in central Taiwan. Tsai KY; Su CC; Chiang CT; Tseng YT; Lian IB Cancer Epidemiol; 2017 Apr; 47():118-124. PubMed ID: 28259083 [TBL] [Abstract][Full Text] [Related]
7. Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia. Brito JA; Gomes CC; Guimarães AL; Campos K; Gomez RS J Oral Pathol Med; 2014 Mar; 43(3):211-6. PubMed ID: 24020903 [TBL] [Abstract][Full Text] [Related]
8. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression. Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811 [TBL] [Abstract][Full Text] [Related]
9. Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study. Sundberg J; Korytowska M; Holmberg E; Bratel J; Wallström M; Kjellström E; Blomgren J; Kovács A; Öhman J; Sand L; Hirsch JM; Giglio D; Kjeller G; Hasséus B PLoS One; 2019; 14(12):e0225682. PubMed ID: 31810078 [TBL] [Abstract][Full Text] [Related]
10. BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation. Klein IP; Meurer L; Danilevicz CK; Squarize CH; Martins MD; Carrard VC J Appl Oral Sci; 2020; 28():e20190532. PubMed ID: 32348447 [TBL] [Abstract][Full Text] [Related]
11. Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study. Wang TY; Chiu YW; Chen YT; Wang YH; Yu HC; Yu CH; Chang YC J Formos Med Assoc; 2018 May; 117(5):374-380. PubMed ID: 29428194 [TBL] [Abstract][Full Text] [Related]
12. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study. von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603 [TBL] [Abstract][Full Text] [Related]
14. Study of the TP53 codon 72 polymorphism in oral cancer and oral potentially malignant disorders in Argentine patients. Zarate AM; Don J; Secchi D; Carrica A; Galindez Costa F; Panico R; Brusa M; Barra JL; Brunotto M Tumour Biol; 2017 May; 39(5):1010428317699113. PubMed ID: 28459200 [TBL] [Abstract][Full Text] [Related]
15. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers. Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449 [TBL] [Abstract][Full Text] [Related]
16. Chewing tobacco may act as a risk factor for dysplastic transformation of squamous cells in Oral leukoplakia- A cytochemistry based approach. Bhattacharyya S; Ray S; Saha D; Mustafi SM; Alam N; Sarkar A; Murmu N Pathol Res Pract; 2021 Feb; 218():153287. PubMed ID: 33454586 [TBL] [Abstract][Full Text] [Related]
17. Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study. Chaturvedi AK; Udaltsova N; Engels EA; Katzel JA; Yanik EL; Katki HA; Lingen MW; Silverberg MJ J Natl Cancer Inst; 2020 Oct; 112(10):1047-1054. PubMed ID: 31860085 [TBL] [Abstract][Full Text] [Related]